Published in Targeted Oncology (ePub 2023 Nov 1), Trilaciclib Enhances Survival in ES-SCLC,
According to Real-World Data, discusses the implications of the findings from data manually
curated by EMOL Health, in collaboration with Ajeet Gajra, MD, and G1 Therapeutics.
For Article link, click here.